Plain-English translation of NCT06685601 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial photobiomodulation (tPBM)—a type of light therapy that shines infrared light onto specific areas of the scalp—to see if it can help children with ADHD improve their attention, focus, and self-control. Researchers will compare the effects of real light therapy against a sham (fake) version to understand whether the treatment actually works.
ADHD affects millions of children and can make it hard to concentrate in school and get along with others. While there are medications and behavioral therapies available, researchers want to explore whether this new light-based treatment could offer another safe option to help children manage their symptoms.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic twice, at least one week apart. During each visit, you'll receive a 12-minute light therapy session—one will be the real treatment and one will be the sham version (you won't know which is which). Before and after each session, doctors and researchers will ask you questions, have you complete some simple tasks, and may record your brain activity and eye movements to see how the treatment affects your focus and behavior.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China